NEW YORK – Personal Genomics, a Taiwan-based sequencing technology firm, has sued Pacific Biosciences in China, alleging patent infringement.
The complaint, filed in the Wuhan People's Court, "asserts that PacBio's Sequel and Sequel II, as well as related commercialization activities by PacBio, its agents and certified service providers, infringe one or more claims of China patent No. CN101743321B," Personal Genomics said in a statement. The patent is for a "Bioassay system including optical detection apparatuses, and method for detecting biomolecules."